Europe & Central Asia (excluding high income) vs Israel: Domestic private health expenditure per capita, PPP

Europe & Central Asia (excluding high income)
521.25 current international $
in 2023
Israel
1,344 current international $
in 2023
Europe & Central Asia (excluding high income) rank
19th
Israel rank
22nd

Domestic private health expenditure per capita, PPP over time

  • Europe & Central Asia (excluding high income)
  • Israel
05001.0k1.5k200020112023

How they compare

Israel currently reports 1,344 current international $ against 521.25 current international $ in Europe & Central Asia (excluding high income), a difference of 822.75 current international $.

That makes Israel's figure about 2.6 times Europe & Central Asia (excluding high income)'s.

Across all 24 years both countries report, Israel has been ahead every year.

Europe & Central Asia (excluding high income) ranks 19th and Israel ranks 22nd of 47 groups.

Israel has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Europe & Central Asia (excluding high income) Israel Difference Ahead
2000s 167.91 current international $ 674.18 current international $ 506.27 current international $ Israel
2010s 296.23 current international $ 921.15 current international $ 624.91 current international $ Israel
2020s 465.57 current international $ 1,233 current international $ 767.62 current international $ Israel

Averages of every year both report within each decade.

Frequently asked questions

Which has higher domestic private health expenditure per capita, ppp, Europe & Central Asia (excluding high income) or Israel?
Israel, at 1,344 current international $ against 521.25 current international $ in Europe & Central Asia (excluding high income) as of 2023.
What is the difference in domestic private health expenditure per capita, ppp between Europe & Central Asia (excluding high income) and Israel?
822.75 current international $, with Israel ahead.
How many years of comparable data are there for Europe & Central Asia (excluding high income) and Israel?
24 years are reported by both, from 2000 to 2023.
How do Europe & Central Asia (excluding high income) and Israel rank globally for domestic private health expenditure per capita, ppp?
Europe & Central Asia (excluding high income) ranks 19th and Israel ranks 22nd of 47 groups.
Where does this data come from?
Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO), published as Domestic private health expenditure per capita, PPP (current international $). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Europe & Central Asia (excluding high income) vs Israel: Domestic private health expenditure per capita, PPP. Statizoid, drawing on Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO). Retrieved 18 September 2026, from https://health.statizoid.com/compare/domestic-private-health-expenditure-per-capita-ppp-current-international/europe-and-central-asia-excluding-high-income/israel/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/domestic-private-health-expenditure-per-capita-ppp-current-international/europe-and-central-asia-excluding-high-income/israel/">Europe & Central Asia (excluding high income) vs Israel: Domestic private health expenditure per capita, PPP</a> — Statizoid

About this data

Indicator
Domestic private health expenditure per capita, PPP (current international $)
Unit
current international $
Source
Global Health Expenditure Database, updated December 12th, 2025, World Health Organization (WHO)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
240 places, 5,674 data points, 2000–2024
Last refreshed

Current private expenditures on health per capita expressed in international dollars at purchasing power parity.